Keyphrases
Immunomodulatory Effect
100%
Lymphokine-activated Killer Cells
100%
Recombinant interleukin-2
100%
High Dose
22%
Peripheral Blood Mononuclear Cells
22%
Natural Killer
22%
Immunological Parameters
22%
Hematological Parameters
22%
Consecutive Patients
11%
Cell Therapy
11%
Daudi
11%
Global Change
11%
Eosinophilia
11%
Tumor Regression
11%
Adoptive Immunotherapy
11%
Cellular Expression
11%
Human Cancer
11%
Bolus
11%
Metastatic Cancer
11%
Cellular Immunotherapy
11%
K562
11%
IL-2 Receptor
11%
Immunological Changes
11%
Lymphocytosis
11%
Hematological Changes
11%
T Cell Activation Markers
11%
Immunology and Microbiology
Low Drug Dose
100%
Lymphokine Activated Killer Cell
100%
Recombinant Interleukin 2
100%
Drug Megadose
22%
Immunotherapy
22%
Peripheral Blood Mononuclear Cell
22%
T Cell Activation
11%
Cell Line
11%
Interleukin 2
11%
Adoptive Immunotherapy
11%